RANDOMISED TRIAL OF INTRAVENOUS STREPTOKINASE, ORAL ASPIRIN, BOTH, OR NEITHER AMONG 17 187 CASES OF SUSPECTED ACUTE MYOCARDIAL INFARCTION: ISIS-2
- 1 August 1988
- journal article
- editorial
- Published by Elsevier in The Lancet
- Vol. 332 (8607), 349-360
- https://doi.org/10.1016/s0140-6736(88)92833-4
Abstract
No abstract availableKeywords
Funding Information
- British Heart Foundation
This publication has 24 references indexed in Scilit:
- Thrombolytic Therapy: Current StatusNew England Journal of Medicine, 1988
- An Overview of the British and American Aspirin StudiesNew England Journal of Medicine, 1988
- United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: interim resultsBMJ, 1988
- Effect of Intravenous Streptokinase on Left Ventricular Function and Early Survival after Acute Myocardial InfarctionNew England Journal of Medicine, 1987
- A Prospective Trial of Intravenous Streptokinase in Acute Myocardial Infarction (I.S.A.M.)New England Journal of Medicine, 1986
- Clinical pharmacology of platelet cyclooxygenase inhibition.Circulation, 1985
- Beta blockade during and after myocardial infarction: An overview of the randomized trialsProgress in Cardiovascular Diseases, 1985
- Thrombolytic TherapyNew England Journal of Medicine, 1984
- Intravenous short-term infusion of streptokinase in acute myocardial infarction.Circulation, 1983
- Stein's Paradox in StatisticsScientific American, 1977